HERON THERAPEUTICS, INC.
HRTX · NASDAQ
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. Heron is developing novel, patient-focused solutions that apply its innovative science and technologies to already-approved pharmacological agents for patients suffering from pain or cancer.
ESG Scores
Overall ESG3.2
Environmental5.3
Social2.7
Governance6.5
Gender Diversity
Female Directors0.2857%
Female Executives0.27586206896551724%
CEO GenderMale
Market Data
Price$0.48+0.04 (+8.21%)
Market Cap$84M
P/E Ratio—
EPS$—
52W High$2.30
52W Low$0.43
Beta1.63